Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,621 | -61,515 | -39,512 | -21,158 | -77,331 |
| Depreciation Amortization | 1,551 | -971 | -966 | -605 | -3,127 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,164 |
| Accounts receivable | N/A | N/A | -3,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,026 | 4,897 | 4,553 | -2,013 | 1,200 |
| Other Working Capital | 1,943 | -913 | -6,361 | -4,596 | -9,659 |
| Other Operating Activity | 6,599 | 5,427 | 5,488 | 5,837 | 33,409 |
| Operating Cash Flow | $-63,502 | $-53,075 | $-39,798 | $-22,535 | $-57,672 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 58,866 | 42,605 | 31,125 | 15,821 | 8,392 |
| PPE Investments | -9 | -9 | N/A | N/A | -237 |
| Investing Cash Flow | $58,857 | $42,596 | $31,125 | $15,821 | $8,155 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 742 | 2 | 2 | 2 | 59,566 |
| Other Financing Activity | -148 | -77 | -69 | -2 | -240 |
| Financing Cash Flow | $594 | $-75 | $-67 | $0 | $59,326 |
| Beginning Cash Position | 20,945 | 20,945 | 20,945 | 20,945 | 11,136 |
| End Cash Position | 16,894 | 10,391 | 12,205 | 14,231 | 20,945 |
| Net Cash Flow | $-4,051 | $-10,554 | $-8,740 | $-6,714 | $9,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,502 | -53,075 | -39,798 | -22,535 | -57,672 |
| Capital Expenditure | -9 | -9 | N/A | N/A | -237 |
| Free Cash Flow | -63,511 | -53,084 | -39,798 | -22,535 | -57,909 |